NATIONAL DISEASE RESEARCH INTERCHANGE (EIN 232213205) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1988

Legal Domicile

Principal Officer

WILLIAM LEINWEBER

Phone

2155577361

Tax Period

2024-01-01 to 2024-12-31

NATIONAL DISEASE RESEARCH INTERCHANGE, founded in 1988, is a mid-sized nonprofit in the Medical Research sector that reported $11.3M in total revenue in fiscal year 2024. Revenue surged 23% from the prior year, signaling strong growth momentum. Expenses of $10.6M left a modest 6% surplus.

Mission

ADVANCING THE PROCUREMENT, PRESERVATION AND DISTRIBUTION OF HUMAN CELLS, TISSUES AND ORGANS FOR BIOMEDICAL RESEARCH, NATIONALLY AND INTERNATIONALLY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $6,620,006

Program Service Revenue $4,608,523

Investment Income $53,935

Other Revenue $0

TOTAL REVENUE $11,282,464

Expense Breakdown

Grants Paid $0

Salaries & Benefits $4,048,366

Fundraising Expenses $0

Program Expenses $7,714,355

Other Expenses $6,535,172

TOTAL EXPENSES $10,583,538

Year-over-Year Comparison

	2024	2023	Change
Revenue	$11,282,464	$9,146,487	+0.2%
Expenses	$10,583,538	$9,254,872	+0.1%
Net Income	$698,926	$-108,385	-7.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$722,492

Total Directors

$501,709

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WILLIAM LEINWEBER	PRESIDENT & CEO	37.50	Officer Director	$432,567	$69,142	$501,709
MARY JC HENDRIX	CHAIR OF THE BOARD	1.00	Officer Director	$0	$0	$0
DAVID M ALBERT	BOARD MEMBER	1.00	Director	$0	$0	$0
SHAWN BLACKBURN	BOARD MEMBER	1.00	Director	$0	$0	$0
SULAYMAN DIB-HAJJ	BOARD MEMBER	1.00	Director	$0	$0	$0
MEGAN KASIMATIS SINGLETON	BOARD MEMBER	1.00	Director	$0	$0	$0
VERA KRYMSKAYA	BOARD MEMBER	1.00	Director	$0	$0	$0
PAUL M LIEBERMAN	BOARD MEMBER	1.00	Director	$0	$0	$0
ROBERT MARCANTUONO	BOARD MEMBER	1.00	Director	$0	$0	$0
JESSICA MULHOLLAND	BOARD MEMBER	1.00	Director	$0	$0	$0
HOWARD M NATHAN	BOARD MEMBER	1.00	Director	$0	$0	$0
LOUIS PHILIPSON	BOARD MEMBER	1.00	Director	$0	$0	$0
ARTHUR H RUBENSTEIN	BOARD MEMBER	1.00	Director	$0	$0	$0
JIM VAUGHT	BOARD MEMBER	1.00	Director	$0	$0	$0
MICHAEL WHITE	BOARD MEMBER	1.00	Director	$0	$0	$0
DEANNE TAYLOR	BOARD MEMBER	1.00	Director	$0	$0	$0
RICHARD HASZ JR	BOARD MEMBER (EFF NOV 2024)	1.00	Director	$0	$0	$0
THOMAS MALECKI	CFO; VP, ADMINISTRATION	37.50	Officer	$214,583	$6,200	$220,783
THOMAS BELL	CHIEF SCIENTIFIC OFFICER	37.50	Highest	$248,259	$12,853	$261,112
MELISSA W VONDRAN	SR VP, OPERATIONS & DIRECTOR BIOREPOSITORY	35.00	Highest	$190,478	$7,472	$197,950
SABOOR A SHAD	DIRECTOR, TISSUE SOURCE SITE MGMT	37.50	Highest	$112,347	$14,773	$127,120
DANA R ROSALES	DIRECTOR, FULFILLMENT	37.50	Highest	$115,055	$40,365	$155,420
SUSAN MCGOVERN	MANAGER HUMAN RESOURCES	37.50	Highest	$107,589	$18,555	$126,144

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$11,282,464	$10,583,538	$7,101,587	$698,926
2023	$9,146,487	$9,254,872	$7,181,811	$-108,385
2022	$7,402,515	$8,132,656	$6,908,115	$-730,141
2021	$7,072,153	$7,003,538	$6,059,781	$68,615
2020	$6,460,315	$7,265,227	$6,399,365	$-804,912
2019	$7,121,789	$7,214,782	$6,065,530	$-92,993
2018	$7,408,450	$7,222,387	$3,796,622	$186,063

NATIONAL DISEASE RESEARCH INTERCHANGE